ExThera Medical Corporation
$1.5M 15 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Invivyd Inc
Invivyd Inc reported $1,522,593.99 across General Payments, Research, and Ownership to 268 physicians and teaching hospitals across 325 transactions.
- $1.5M Above-median payer
- All-tracks total
- 325 Above-median volume
- Transactions
- 268 Above-median reach
- Recipients
- #520
- of 1,925 companies
Invivyd Inc reported $1,522,593.99 across all CMS Open Payments tracks (General + Research + Ownership) to 268 physicians and teaching hospitals in Program Year 2024 - ranking #520 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $70,506.52, averaging $5.7K per recipient.
How Invivyd Inc's $1.5M all-tracks total breaks down
Invivyd Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
25/100
Total payments
F
24/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer invivyd-inc Invivyd Inc
$1.5M · #520/1,925 · 0.0% industry · PY2024
- TOT $1.5M
- RANK #520
- SHARE 0.0%
- TXN 325
- RCP 268
- CAT 4
- GEN $70.5K
- TOP1 11.3%
- PY 2024
Volume peers
Nearest volume peer: ExThera Medical Corporation ($1.5M)
Invivyd Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Invivyd Inc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Invivyd Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 4 general-payment categories charted below, "Consulting Fee" is the largest at $39.7K across 21 transactions, 56.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 4 types of general payments, Invivyd Inc's largest category was "Consulting Fee" at $39.7K - 56.3% of General Payments.
Invivyd Inc reports 4 general-payment categories - the top three are Consulting Fee (56.3%), Space Rental or Facility Fees (29.4%), and Food and Beverage (7.5%). The remaining 1 category make up 6.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Invivyd Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $39.7K | 21 | 56.3% |
| Space Rental or Facility Fees | $20.8K | 9 | 29.4% |
| Food and Beverage | $5.3K | 236 | 7.5% |
| Compensation for Services Other Than Consulting | $4.8K | 2 | 6.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $25,323.51 (35.9%) of $70,506.52 in this company's General Payments records across 243 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Invivyd Inc
The five named recipients with the highest reported General Payments from this company
- 1
Scripps Green Hospital
$8,000.00 across 2 reported transactions
- 2
Ucsf Medical Center
$6,000.00 across 2 reported transactions
- 3
Mayo Clinic Hospital Rochester
$5,004.00 across 2 reported transactions
- 4
Cedric Spak
$3,694.51 across 4 reported transactions
- 5
Kassem Safa
$2,625.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Invivyd Inc ranks #520 of 1,925 by total payments (top 27% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,323 of 1,838 by HHI (bottom 28% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Kite Pharma, Inc. : $1.3M total payments, HHI 462
- Musculoskeletal Transplant Foundation Inc. : $1.7M total payments, HHI 461
- MED-EL Corporation : $1.1M total payments, HHI 459
- Fusion Orthopedics USA, LLC : $655.1K total payments, HHI 458
- Dentsply LLC : $290.4K total payments, HHI 457
- Bayer Healthcare Pharmaceuticals Inc. : $11.5M total payments, HHI 456
- Invivyd Inc (this company) : $70.5K total payments, HHI 455
- DENTSPLY Canada Ltd : $22.0K total payments, HHI 452
- Molnlycke Health Care US, LLC : $392.2K total payments, HHI 451
- VOCO America Inc. : $189.4K total payments, HHI 451
- Think Surgical, Inc. : $103.4K total payments, HHI 450
- Neuronetics, Inc. : $1.1M total payments, HHI 449
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Invivyd Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Invivyd Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Invivyd Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Collegium Pharmaceutical, Inc.
$1.5M 36,863 recipients
Compare payment profiles
Fresenius Kabi USA, LLC
$1.5M 8,126 recipients
Compare payment profiles
Balt USA, LLC
$1.5M 1,737 recipients
Compare payment profiles
Instylla, Inc.
$1.5M 124 recipients
Compare payment profiles
VectivBio AG
$1.5M 10 recipients
Compare payment profiles
Put this to use
Invivyd Inc ranks #520 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Invivyd Inc sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Invivyd Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.